Significance of analyzing circulating plasma cells in multiple myeloma: differences from measuring minimal residual diseases in bone marrow
Leuk Lymphoma
.
2022 Feb;63(2):487-490.
doi: 10.1080/10428194.2021.1992765.
Epub 2021 Nov 2.
Authors
Sung-Min Kim
1
,
Youngeun Lee
2
,
Dajeong Jeong
2
,
Jiwon Yun
2
,
Sung-Soo Yoon
3
,
Sang Mee Hwang
4
,
Nuri Lee
5
,
Dong Soon Lee
1
2
Affiliations
1
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
2
Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
3
Department of Internal Medicine, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.
4
Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
5
Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
PMID:
34727831
DOI:
10.1080/10428194.2021.1992765
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Bone Marrow
Humans
Multiple Myeloma* / diagnosis
Neoplasm, Residual / diagnosis
Neoplastic Cells, Circulating*
Plasma Cells